Post Profile

Senators ask Justice Dept to consider probe of EpiPen Medicaid classification

WASHINGTON (Reuters) - U.S. Senators Richard Blumenthal, Charles Grassley and Amy Klobuchar asked the Justice Department to investigate whether Mylan NV may have misclassified its EpiPen in order to pay lower rebates to the states.
read more


Related Posts

U.S. Senate committee chair: Mylan's response on EpiPen price hike 'incomplete'

Health : Reuters: Health

WASHINGTON (Reuters) - The chairman of the U.S. Senate Judiciary Committee probing Mylan NV's EpiPen price hike on Friday said its response to his query was "incomplete," and called on the drugmaker to give more details over how muc...

Senate investigations panel to probe Mylan's EpiPen pricing

Health : Reuters: Health

WASHINGTON (Reuters) - The U.S. Senate's permanent subcommittee on investigations has decided to look into Mylan Pharmaceuticals' pricing of the EpiPen, according to a press release issued on Wednesday.

West Virginia investigating Mylan over EpiPen pricing

Health : Reuters: Health

NEW YORK (Reuters) - The state of West Virginia is investigating whether Mylan NV violated antitrust law or defrauded the state's Medicaid program in connection with its EpiPen device.

U.S. lawmakers question Mylan's Medicaid EpiPen rebates

Health : Reuters: Health

(Reuters) - Two key U.S. congressional committee members on Friday called for an investigation into whether Mylan NV, under fire for raising the price of its EpiPen device, overcharged the government's low-income healthcare program ...

U.S. agency says it advised Mylan that EpiPen was misclassified

Health : Reuters: Health

WASHINGTON (Reuters) - A U.S. health agency said on Wednesday it had "expressly advised" Mylan that the company had misclassified the EpiPen in a way that led to the company paying a lower rebate to states.


Copyright © 2016 Regator, LLC